Here are five notes:
1. The style score is calculated based on a series of factors indicating whether the stock is at a favorable level to enter a position based on the recent upward or downward movement of the equity.
2. Only expert traders use this strategy, which is determined by short-term price movements rather than company fundamentals or research.
3. Based on a consensus basis, brokerage firm research analysts predict Integra LifeSciences‘ stock to increase to $65.50.
4. Analysts at Zacks placed a stock rating of 2.14 on the equity of Integra‘s LifeSciences‘ stock.
5. Analysts predict Integra LifeSciences will report earnings of $0.76 per share on August 8, 2015.
For more articles on device news:
Hill-Rom purchases Welch Allyn for $2.05B — 7 key notes
Blue Belt, SurgCenter Development partner for orthopedic robotics: 5 key notes
Michael Turpin joins K2M board of directors — 5 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
